Cites Higher Risks Of Neural Tube Defects Like Spina Bifida, Hypospadias, And Other Birth Defects As Well As Increased Risk Of Autism Spectrum Disorder
SUMMARY: We have written several articles about the birth defects or congenital malformations and developmental problems that have been associated with Depakote, Depakote CP, and Depakote ER, as well as Depacon and Depakene.
Now more restrictions of the use of these valproate drugs by women who may become pregnant have been recommended by a European drug regulatory committee.
We will continue to monitor the safety profile of Depakote / Depakene / Depacon, valproate medications from AbbVie Inc. (formerly Abbott) for seizures, epilepsy, bipolar disorder, and (until recently) migraine headaches.[Read this article in full at original source]
Strictly Confidential, No Obligation.